The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.
Abstract
The recombinant dengue virus type-4 vaccine candidate 2AA30 was attenuated in rhesus monkeys due to an engineered 30-nucleotide deletion in the 3'-untranslated region of the viral genome. A clinical trial to evaluate the safety and immunogenicity of a single dose of 2Adelta30 was conducted with 20 adult human volunteers. The vaccine candidate was well tolerated and did not cause systemic illness in any of the 20 volunteers. Viremia was detectable in 14 volunteers at a mean level of 1.6 log10 plaque-forming units/ml of serum, although all 20 volunteers seroconverted with a seven-fold or greater increase in serum neutralizing antibody titer on day 28 post-vaccination (mean titer = 1:580). A mild, asymptomatic, macular rash developed in 10 volunteers, and a transient elevation in the serum level of alanine aminotransferase was noted in five volunteers. The low level of reactogenicity and high degree of immunogenicity of this vaccine candidate warrant its further evaluation and its use to create chimeric vaccine viruses expressing the structural genes of dengue virus types 1, 2, and 3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Techniques for Hemagglutination and Hemagglutination-Inhibition with Arthropod-Borne Viruses
Clarke, D. H., & Casals, J. (1958) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1958.7.561 · Cited by 2,045
A Prospective Study of Dengue Infections in Bangkok
Burke, D. S., Nisalak, A., Johnson, D. E., & Scott, R. M. (1988) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.172 · Cited by 828
A Plaque Reduction Test for Dengue Virus Neutralizing Antibodies
Russell, P. K., Nisalak, A., Sukhavachana, P., & Vivona, S. (1967) · The Journal of Immunology · doi:10.4049/jimmunol.99.2.285 · Cited by 425
Risk Factors in Dengue Shock Syndrome
Thein, S., Aung, M. M., Shwe, T. N., Aye, M., Zaw, A., Aye, K., Aye, K. M., & Aaskov, J. (1997) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1997.56.566 · Cited by 364
Liver Biochemical Tests and Dengue Fever
Kuo, C.-H., Tai, D.-I., Changchien, C., et al. (1992) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1992.47.265 · Cited by 343
Impact of Dengue/Dengue Hemorrhagic Fever on The Developing World
Gubler, D. J., & Meltzer, M. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60342-5 · Cited by 318
Halstead, S. B., Scanlon, J. E., Umpaivit, P., & Udomsakdi, S. (1969) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1969.18.997 · Cited by 303
Widespread intra-serotype recombination in natural populations of dengue virus
Worobey, M., Rambaut, A., & Holmes, E. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7352 · Cited by 257
Natural genetic exchanges between vaccine and wild poliovirus strains in humans.
Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F., & Crainic, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8434-8443.2000 · Cited by 202
Butrapet, S., Huang, C. Y.-H., Pierro, D. J., Bhamarapravati, N., Gubler, D. J., & Kinney, R. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3011-3019.2000 · Cited by 173
The nucleotide sequence of dengue type 4 virus: Analysis of genes coding for nonstructural proteins
Mackow, E. R., Makino, Y., Zhao, B., Zhang, Y., Markoff, L. J., Buckler-White, A. J., Guiler, M., Chanock, R. M., & Lai, C. (1987) · Virology · doi:10.1016/0042-6822(87)90458-2 · Cited by 157
Self-citationBhamarapravati, N., Yoksan, S., Chayaniyayothin, T., Angsubphakorn, S., & Bunyaratvej, A. (1987) · Europe PMC (PubMed Central) · Cited by 150
Lee, E., Weir, R. C., & Dalgarno, L. (1997) · Virology · doi:10.1006/viro.1997.8570 · Cited by 111
Rosen, L. E., Drouet, M., & Deubel, V. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.61.720 · Cited by 106
Recent Advances in Our Knowledge of Dengue and Sandfly Fever
Sabin, A. B. (1955) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1955.4.198 · Cited by 89
Lack of Attenuation of a Candidate Dengue 1 Vaccine (45AZ5) in Human Volunteers
McKee, K. T., Bancroft, W. H., Eckels, K. H., Redfield, R., Summers, P. L., & Russell, P. K. (1987) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1987.36.435 · Cited by 85
Edelman, R., Tacket, C. O., Wasserman, S. S., Vaughn, D. W., Eckels, K. H., Dubois, D. R., Summers, P. L., & Hoke, C. H. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1448 · Cited by 83
Self-citation
Cited by
Prospects for a dengue virus vaccine
Whitehead, S. S., Blaney, J. E., Durbin, A. P., & Murphy, B. R. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1690 · Cited by 623
Self-citationMonath, T. P. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.4.553 · Cited by 467
Dengue diagnosis, advances and challenges
Guzmán, M. G., & Kourı́, G. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.03.003 · Cited by 374
Dengue: defining protective versus pathologic immunity
Rothman, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421512 · Cited by 364
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
Barrett, P. N., Mundt, W., Kistner, O., & Howard, M. K. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.19 · Cited by 281
Metadata
- Authors
- Durbin, A. P., Karron, R. A., Sun, W., Vaughn, D. W., Reynolds, M. J., Perreault, J. R., Thumar, B., Men, R., Lai, C. J., Elkins, W. R., Chanock, R. M., Murphy, B. R., & Whitehead, S. S.
- Venue
- The American journal of tropical medicine and hygiene
- Published
- 2001-11
- Volume
- 65
- Issue
- 5
- Pages
- 405-413
- ISSN
- 0002-9637 (ISSN-L)
- OpenAlex
- W2157955177
- Cited by
- 287
- References
- 17
- FWCI
- 17.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.